Literature DB >> 14577070

The spectrum of surgical jaundice in infancy.

Mark Davenport1, P Betalli, L D'Antiga, P Cheeseman, G Mieli-Vergani, E R Howard.   

Abstract

BACKGROUND: Conjugated jaundice arising during infancy may be caused by a number of different surgical conditions. The aim of this study was to compare clinical features, management, and outcome of all types of surgical jaundice presenting in the first year of life.
METHODS: A retrospective review was conducted of all infants born in the United Kingdom with jaundice caused by a surgical cause referred to the authors' institution from January 1992 to December 1999.
RESULTS: There were 171 infants who could be separated into 3 specific groups: biliary atresia (BA, n = 137), inspissated bile syndrome (IBS; n = 14), and choledochal malformation (CM; n = 12) together with a group containing various miscellaneous conditions (n = 8). Infants with BA had higher bilirubin (P <.01) and aspartate aminotransferase levels (P <.001) and came to surgery earlier (P <.01) than infants with either IBS or CM. Infants with IBS and CM were more likely to be premature and have other malformations, respectively. Ultrasound scan was the principal investigation in the differentiation of BA from other causes of jaundice. Accurate prelaparotomy diagnosis was made by percutaneous liver biopsy in 87% of cases later shown to be BA. Currently, 88 (64%) of children with BA are alive with their native liver postportoenterostomy, 4 have died, and 45 have undergone liver transplantation (with 1 death postoperatively). A policy of primary portoenterostomy for BA followed by transplantation, if necessary, resulted in a survival rate of over 95%. All children in the other diagnostic groups are alive and anicteric after appropriate surgical intervention.
CONCLUSIONS: Approximately 80% of infants presenting with surgical jaundice have biliary atresia, whereas those with inspissated bile syndrome and choledochal malformations make up most of the remainder. Mortality in this age-group is confined to infants with BA, but even on these infants an overall survival rate of greater than 95% is currently expected.

Entities:  

Mesh:

Year:  2003        PMID: 14577070     DOI: 10.1016/s0022-3468(03)00498-6

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  8 in total

1.  Spontaneous perforation of the biliary tract and portal vein thrombosis in infancy.

Authors:  Emily Livesey; Mark Davenport
Journal:  Pediatr Surg Int       Date:  2007-07-17       Impact factor: 1.827

2.  Laparoscopic cholecystostomy and bile duct lavage for treatment of inspissated bile syndrome: a single-center experience.

Authors:  Zhi-Gang Gao; Min Shao; Qi-Xing Xiong; Jin-Fa Tou; Wei-Guang Liu
Journal:  World J Pediatr       Date:  2011-08-07       Impact factor: 2.764

Review 3.  Biliary atresia: outcome and management.

Authors:  Mark Davenport
Journal:  Indian J Pediatr       Date:  2006-09       Impact factor: 1.967

4.  Use of Omega-3 Polyunsaturated Fatty Acids to Treat Inspissated Bile Syndrome: A Case Report.

Authors:  Woo Young Jun; Min Jeng Cho; Hye Seung Han; Sun Hwan Bae
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2016-12-28

5.  Percutaneous Transhepatic Biliary Drainage in a Two-Month-Old Infant with Inspissated Bile Syndrome.

Authors:  Sung Hui Chang; Seung Moon Joo; Choon Sik Yoon; Kwang Hun Lee; Soon Min Lee
Journal:  Yonsei Med J       Date:  2018-09       Impact factor: 2.759

6.  Biomarkers for the diagnosis and post-Kasai portoenterostomy prognosis of biliary atresia: a systematic review and meta-analysis.

Authors:  Lin He; Dennis Kai Ming Ip; Greta Tam; Vincent Chi Hang Lui; Paul Kwong Hang Tam; Patrick Ho Yu Chung
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

7.  Biliary atresia.

Authors:  C K Sinha; Mark Davenport
Journal:  J Indian Assoc Pediatr Surg       Date:  2008-04

8.  Rainbow of colors: Inspissated bile syndrome secondary to hemolytic disease of the newborn and concomitant serum dynamics.

Authors:  Veronica Mugarab Samedi; Mehrieh Rahimi; Kaartigean Kalaniti; Martha Lyon; Sibasis Daspal
Journal:  SAGE Open Med Case Rep       Date:  2021-06-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.